Surrogate isotope-containing materials for emergency response training and Methods of formation and dispersal

US11276508B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11276508-B2
Application numberUS-201816228465-A
CountryUS
Kind codeB2
Filing dateDec 20, 2018
Priority dateDec 20, 2018
Publication dateMar 15, 2022
Grant dateMar 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Surrogate materials are in the form of solid particles that include surrogate isotopes, namely, short-lived isotopes selected and formed to serve as surrogates for the radioactive materials of a nuclear fallout without including isotopes that are, or that decay to, biologically or environmentally deleterious and persistent isotopes. The surrogate material may be formed using high-purity reactant material and irradiation and separation techniques that enable tailoring of the isotopes and ratios thereof included in the surrogate material, and the surrogate material may be dispersed, e.g., in a training environment, in solid form.

First claim

Opening claim text (preview).

What is claimed is: 1. A surrogate material for emulating nuclear fallout debris, the surrogate material comprising: solid particles comprising at least one surrogate isotope exhibiting a half-life of less than about three days, the at least one surrogate isotope selected from the group consisting of potassium-42, bromine-82, scandium-44, scandium-44m, copper-64, barium-140, lanthanum-140, zirconium-95, zirconium-97, tellurium-132, dysprosium-166, holmium-166, and molybdenum-99, wherein at least some of the solid particles are not encapsulated in another material and comprise activated potassium bromide (KBr) salt particles comprising at least one of the potassium-42 or the bromine-82; and wherein at least some others of the solid particles comprise a matrix material encapsulating at least one other surrogate isotope, the at least one other surrogate isotope selected from the group consisting of the scandium-44, the scandium-44m, the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99. 2. The surrogate material of claim 1 , wherein the matrix material is silica glass. 3. The surrogate material of claim 1 , wherein at least a portion of the at least some others of the solid particles each comprise only one surrogate isotope selected from the group consisting of the scandium-44, the scandium-44m, the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99. 4. The surrogate material of claim 3 , wherein at least another portion of the at least some others of the solid particles each comprise at least one other surrogate isotope selected from the group consisting of the scandium-44, the scandium-44m, the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99. 5. The surrogate material of claim 1 , wherein the at least one surrogate isotope exhibits a half-life of less than two days. 6. The surrogate material of claim 1 , wherein the surrogate material is free of isotopes with half-lives greater than three days. 7. A method for dispersing a surrogate material for nuclear fallout training, the method comprising: providing a surrogate material comprising solid particles comprising at least one surrogate isotope exhibiting a half-life of less than about three days, the at least one surrogate isotope selected from the group consisting of potassium-42, bromine-82, scandium-44, scandium-44m, copper-64, barium-140, lanthanum-140, zirconium-95, zirconium-97, tellurium-132, dysprosium-166, holmium-166, and molybdenum 99; and dispersing the solid particles of the surrogate material at a training facility, wherein at least some of the solid particles are not encapsulated in another material and comprise activated potassium bromide (KBr) salt particles comprising at least one of the potassium-42 or the bromine-82, and wherein at least some others of the solid particles comprise a matrix material encapsulating at least one other surrogate isotope, the at least one other surrogate isotope selected from the group consisting of the scandium-44, the scandium-44m, the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99. 8. The method of claim 7 , wherein dispersing the solid particles of the surrogate material at a training facility comprises dispersing the solid particles without adding a liquid or solution to the surrogate material. 9. A method for forming a surrogate material for emulating nuclear fallout debris, the method comprising irradiating a high-purity reactant material by neutron irradiation or Bremsstrahlung irradiation to form the surrogate material comprising solid particles comprising at least one surrogate isotope exhibiting a half-life of less than about three days, the at least one surrogate isotope selected from the group consisting of potassium-42, bromine-82, scandium-44, scandium-44m, copper-64, barium-140, lanthanum-140, zirconium-95, zirconium-97, tellurium-132, dysprosium-166, holmium-166, and molybdenum-99, wherein at least some of the solid particles are not encapsulated in another material and comprise activated potassium bromide (KBr) salt particles comprising at least one of the potassium-42 or the bromine-82, and wherein at least some others of the solid particles comprise a matrix material encapsulating at least one other surrogate isotope, the at least one other surrogate isotope selected from the group consisting of the scandium-44, the scandium-44m, the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99. 10. The method of claim 9 , wherein the method comprises irradiating a high-purity potassium bromide (KBr) salt by the neutron irradiation to form the activated KBr salt particles comprising the at least one of the potassium-42 or the bromine-82. 11. The method of claim 9 , wherein the method comprises irradiating high-purity scandium-45 material by the Bremsstrahlung irradiation to form the at least some others of the solid particles comprising at least one of the scandium-44 or the scandium-44m. 12. The method of claim 11 , wherein the method comprises, before irradiating the high-purity scandium-45 material, encapsulating the high-purity scandium-45 material in the matrix material, the matrix material comprising glass. 13. The method of claim 9 , wherein the high-purity reactant material comprises: a KBr salt from which the at least some of the solid particles are formed; and at least one of uranium, thorium, or actinium, from which the at least some others of the solid particles are formed. 14. The method of claim 13 , wherein the method comprises: irradiating the at least one of the uranium, the thorium, or the actinium by the Bremsstrahlung irradiation to form fission products; removing from the fission products isotopes with half-lives of greater than three days, leaving fission products exhibiting short half-lives; separating, from the fission products exhibiting the short half-lives, at least one Bremsstrahlung-irradiation-derived surrogate isotope to provide the at least one other surrogate isotope, the at least one Bremsstrahlung-irradiation-derived surrogate isotope being selected from the group consisting of the copper-64, the barium-140, the lanthanum-140, the zirconium-95, the zirconium-97, the tellurium-132, the dysprosium-166, the holmium-166, and the molybdenum-99; and after the separating, encapsulating the at least one Bremsstrahlung-irradiation-derived surrogate isotope in the matrix material. 15. The method of claim 14 , wherein removing from the fission products isotopes with half-lives of greater than three days comprises using resins selective for at least one of uranium and strontium. 16. The method of claim 14 , wherein encapsulating the at least one Bremsstrahlung-irradiation-derived surrogate isotope in the matrix material comprises synthesizing high-purity silica glass by a sol-gel reaction.

Assignees

Inventors

Classifications

  • G21G1/06Primary

    by neutron irradiation · CPC title

  • Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for · CPC title

  • Core design; core simulations; core optimisation · CPC title

  • Radioactive sources (producing neutrons or other subatomic particles, X- or gamma rays, in fusion reactors G21B, in nuclear reactors G21C, by cosmic radiation G21H7/00, in accelerators H05H; X-ray tubes H01J35/00; gamma masers H01S4/00) · CPC title

  • Radioactive sources other than neutron sources (radioactive dressings A61N5/1029) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11276508B2 cover?
Surrogate materials are in the form of solid particles that include surrogate isotopes, namely, short-lived isotopes selected and formed to serve as surrogates for the radioactive materials of a nuclear fallout without including isotopes that are, or that decay to, biologically or environmentally deleterious and persistent isotopes. The surrogate material may be formed using high-purity reactan…
Who is the assignee on this patent?
Battelle Energy Alliance Llc
What technology area does this patent fall under?
Primary CPC classification G21G1/06. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).